IOVA Net Income Growth
Iovance Biotherapeutics Inc · Net Income Growth
IOVA Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported25.75%period ending
IOVA TTM Net Income YoY % (72.40% → 25.75%)
Year-over-year change
High-resolution chart · PNG
IOVA net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 25.7498% | |
| 5.7288% | |
| -5.0516% | |
| 3.0156% | |
| 11.4251% | |
| 16.5195% | |
| 16.1833% | |
| 5.3074% | |
| -5.1049% | |
| -9.2279% | |
| -12.1609% | |
| -11.0471% | |
| -11.2715% | |
| -14.8562% | |
| -15.673% | |
| -25.2426% | |
| -32.6464% | |
| -35.0274% | |
| -31.8479% | |
| -22.2047% | |
| -15.5087% | |
| -15.3058% | |
| -31.3962% | |
| -52.9463% | |
| -62.7954% | |
| -71.7726% | |
| -59.8608% | |
| -42.5333% | |
| -43.4768% | |
| -36.8967% | |
| -34.2327% | |
| -42.6867% | |
| -33.9711% | |
| -46.7823% | |
| -74.0538% | |
| -79.674% | |
| -127.8302% | |
| -127.9124% | |
| -91.1118% | |
| -88.6126% | |
| -78.2669% | |
| -94.1418% | |
| -129.9709% | |
| -29.4776% | |
| 23.5243% | |
| 43.3239% | |
| 52.5845% | |
| -79.1439% | |
| -1,400.9501% | |
| -1,975.5289% | |
| -667.2914% | |
| 31.1186% | |
| 91.6922% | |
| 104.5886% | |
| 87.1254% | |
| 16.357% | |
| -56.1633% | |
| -1,368.3348% | |
| -1,497.5786% | |
| -1,981.8416% | |
| -8,108.7476% | |
| -2,638.9758% | |
| -10,097.2419% | |
| -3,028.5936% | |
| -490.7644% | |
| -99.8128% | |
| 72.3976% |